| Gene symbol | TNFRSF17 | Synonyms | BCM, BCMA, CD269, TNFRSF13A | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p13.13 | dbXrefs | |
| Description | TNF receptor superfamily member 17 | ||||
| GTO ID | GTC3333 |
| Trial ID | NCT05722418 |
| Disease | Multiple Myeloma |
| Altered gene | BCMA |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CB-011 |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma |
| Year | 2023 |
| Country | United States |
| Company sponsor | Caribou Biosciences, Inc. |
| Other ID(s) | CB11A |
| Cohort 1 | |||||||||||
|
|||||||||||